Norway Life Science Trend Analysis 2024

In 2023, the Norwegian life science industry continues to show dynamism and innovation. With biotechnology companies comprising a substantial 48% of the life science sector, nearly half of these fall under the “Biotech – Other” category, which includes sectors such as AgBio, environmental, veterinary, and industrial biotechnology. Notably, digital health emerges as a key sector, … Continue reading Norway Life Science Trend Analysis 2024

Read more

Introducing the New Version of Biotechgate

We are pleased to announce the upcoming launch of a new version of the Biotechgate database, scheduled for the end of May. The release features an enhanced user experience and several new functionalities, including a new M&A section and access to analyst reports and forecasts. In this article, be introduced to the potential of the … Continue reading Introducing the New Version of Biotechgate

Read more

Biotechgate Announces Collaboration with PharmaTell to Deliver Cutting-Edge Analyst Reports

ZURICH, Switzerland, May 2024 – Biotechgate, a leading provider of life sciences information and partnering solutions, is delighted to announce its strategic collaboration with PharmaTell, a respected provider of high-quality analyst reports covering the entire healthcare industry. This partnership aims to enhance the new version of the Biotechgate database by implementing PharmaTell’s analyst reports, providing … Continue reading Biotechgate Announces Collaboration with PharmaTell to Deliver Cutting-Edge Analyst Reports

Read more

Life Sciences M&A Report 2023

2023 showed slow signs of recovery for global life science M&A activity compared to the previous year, both in terms of the number and value of deals. While the macroeconomic challenges and uncertainty in the geopolitical landscape that fueled the 2022 slowdown carried over into 2023, there are indications that dealmakers were approaching 2023 with … Continue reading Life Sciences M&A Report 2023

Read more

Taiwan Life Science Trend Analysis 2024

While 2023 shows a declining trend in terms of private equity financing of Taiwanese life science companies since 2020, public financing surged year-on-year, raising more than twice as much as in 2022. The three largest private equity financing rounds in 2023 were completed by medical technology companies, led by Syncell, which raised USD 8 million. … Continue reading Taiwan Life Science Trend Analysis 2024

Read more

How the Life Sciences Industry Integrates Industry 4.0 Concepts

Industry 4.0 is a concept that represents the integration of advanced digital technologies into manufacturing and production processes. Leveraging technologies such as the Internet of Things (IoT) and artificial intelligence (AI) within the life sciences industry enhances drug discovery, patient communication, and more. In this article, we explore three key trends surrounding Industry 4.0, and … Continue reading How the Life Sciences Industry Integrates Industry 4.0 Concepts

Read more

5 Digital Therapeutics Companies To Watch

Digital therapeutics (DTx) is a rapidly evolving field that seeks to revolutionize healthcare delivery. Considered a subset of digital health, DTx is defined as evidence-based therapeutic interventions driven by software to prevent, manage, or treat a medical disorder or disease. In this article, we’ll explore five companies pioneering innovations in the DTx space. Biofourmis View … Continue reading 5 Digital Therapeutics Companies To Watch

Read more

Keep Track of Industry News on Biotechgate

The life science industry is constantly changing, with new organizations being formed, clinical trials progressing and companies receiving new sources of finance. To stay up-to-date on the latest evolvements within the life science sector, Biotechgate contains a news section with the latest industry and company news provided to you for free. The news section gives … Continue reading Keep Track of Industry News on Biotechgate

Read more

Canadian Life Science Trend Analysis 2024

In 2023, the Canadian biotech landscape showed stability, largely maintaining the financing levels of the previous year (USD 451 million in 2023 vs. USD 460 million in 2022), but falling short of the record year of 2021. Ontario once again proved to be Canada’s most active province, with the highest number of biotech companies and … Continue reading Canadian Life Science Trend Analysis 2024

Read more

Dutch Life Science Trend Analysis 2024: Market is slowly picking up

Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2024 of the Dutch life sciences sector in collaboration with hollandbio. In 2022, the Dutch biotech landscape saw a sharp 50% decline in venture financing, reflecting the challenging global economic climate. Fortunately, the tide seems to turn. In 2023, life sciences saw a … Continue reading Dutch Life Science Trend Analysis 2024: Market is slowly picking up

Read more